Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

A focal ischemic stroke of the somatosensory thalamus produces persistent spontaneous pain-like behavior.

Neurobiology of disease·2026
Same author

First Structure-Activity-Relationship Study of Potent G2A Antagonists.

Journal of medicinal chemistry·2026
Same author

GPCR Biased Signaling: Opportunities and Challenges.

Biochemistry·2026
Same author

Structural characterization of kappa-opioid receptor dimer in complex with two G proteins.

Nature communications·2026
Same author

Toward a Random Background for Ligand Optimization.

bioRxiv : the preprint server for biology·2026
Same author

De novo design of miniproteins targeting GPCRs.

Nature·2026
Same journal

Small Molecules in Development for the Treatment of Sepsis: Insights into Drug Targets and Molecular Mechanisms.

Journal of medicinal chemistry·2026
Same journal

Isofagomine Derivatives as TcdB Glucosyltransferase Inhibitors.

Journal of medicinal chemistry·2026
Same journal

The One-Step Incorporation of Boron-10 Atom into Prostate Cancer-Targeted Fluorophores for Visualizing In Vivo Boron-10 Delivery and Intratumoral Distribution with Cellular Resolution.

Journal of medicinal chemistry·2026
Same journal

Design and Evaluation of Conformationally Locked Indole-Carboxylic Acids as Selective THRβ Agonists against MASH.

Journal of medicinal chemistry·2026
Same journal

Drug Screening of Nitroreductase Modulators Using an Atomic-Engineered Activatable Fluorescent Probe for Tumor Imaging.

Journal of medicinal chemistry·2026
Same journal

Reprogramming Acetaminophen Metabolism via Amide-to-Thioamide Modification to Prevent Drug-Induced Liver Injury.

Journal of medicinal chemistry·2026
関連記事をすべて見る

関連する実験動画

Updated: Jun 6, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

ポリファーマコロジー用大型図書館ドッキング

Yujin Wu1, Seth Vigneron1, Joao Braz2

  • 1Department of Pharmaceutical Chemistry, University of California, San Francisco, 1700 fourth St., Byers Hall Suite 508D, San Francisco, California 94158, United States.

Journal of medicinal chemistry
|February 19, 2026
PubMed
まとめ
この要約は機械生成です。

大型図書館のドッキングでは,複雑な疾患に対する二重活性分子が特定されました. 痛み,うつ,不安に対する強力な化合物が発見されましたが,その有効性を最適化するには課題が残っています.

さらに関連する動画

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

関連する実験動画

Last Updated: Jun 6, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

科学分野:

  • 計算化学はコンピュータ化学である.
  • 薬理学 薬理学とは
  • ドラッグ・ディスカバリー・ドラッグ・ディスカバリー

背景:

  • 複数の生物学的標的を同時に標的にするポリファーマコロジは,複雑な疾患の治療に有望な戦略を提供します.
  • 特定の標的ペアに対する共同活性を持つ分子を特定することは,効果的なマルチターゲットの治療法の開発に不可欠です.

研究 の 目的:

  • 選択されたターゲットペアに対して二重活性分子を発見するための大型ライブラリドッキングの有用性を調査する.
  • alpha2A/SERT,MOR/SERT,およびalpha2A/MORのターゲットに対する潜在的なドッキングを通じて,潜在的な鎮痛剤化合物を特定する.

主な方法:

  • 図書館の成長と二重活動分子識別の遡及的分析.
  • 3つのターゲットペアに対してドッキングを使用して9億個の分子ライブラリの将来の仮想スクリーニング.
  • クリオ電子顕微鏡 (cryo-EM) 構造を用いたドッキング予測ポーズの確認.
  • マウスの行動性アッセイにおける化合物の有効性のインビボ評価.

主要な成果:

  • ドッキングキャンペーンは,低μMから高nMの活動と,alpha2A/SERTとSERT/MORのターゲットに対する高いヒット率を持つ二重結合体を特定しました.
  • アルファ2A/SERTキャンペーンのテトラヒドロピリジン化合物も,5-HT2Aに対する活性を示した.
  • Cryo-EMはドッキングで予測されたポーズを確認したが,その後の最適化は効力を改善する課題に直面した.
  • 鉛のアルファ2A/SERT化合物 (z7149) は,条件付きの場所偏好なしに痛みの測定において有効性を示し,抗うつ剤や抗不安剤のような行動を示した.

結論:

  • 大型図書館のドッキングは,複合薬剤の発見のための実行可能な戦略であり,複雑な状態のための有望なヒットをもたらします.
  • 構造的な検証にもかかわらず,識別された二重活性分子の効能を最適化することは大きな課題を提示します.
  • この研究は,治療上の利益のためにポリファーマコロジーの進歩におけるコンピューティング・ドッキングの可能性と限界の両方を強調しています.